KCK Medtech
VC Fund
Campbell, United States
KCK Medtech is a venture capital and private equity that specializes in financial and investment industry.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries KCK Medtech invests in
Stages KCK Medtech invests in
Countries KCK Medtech invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 5 (83%)
- Medical Device 4 (67%)
- Biotechnology 2 (33%)
- Medical 1 (17%)
- Therapeutics 1 (17%)
Stage
- Series B 3 (50%)
- Series A 1 (17%)
- Funding Round 1 (17%)
- Private Equity 1 (17%)
Country
- United States 4 (67%)
- Israel 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
John White
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
Susan P Stimson
Executive In Residence
|
Executive In Residence | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | $32.5M / Private Equity / Jan 13, 2025 | ||
| ABOUT SONEX HEALTH “Refined simplicity” is the guiding principle behind Sonex Health, LLC, to drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians Darryl Barnes, MD and Jay Smith, MD and business operations expert Aaron Keenan founded Sonex Health in2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.ABOUT THE SX-One MicroKnife The ultra-low profile SX-One MicroKnife with Meerkat Technology™ is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives. | $40M / Series B / Sep 13, 2023 | ||
| Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia. | $30M / Series B / Jul 09, 2023 | ||
| Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California. | $35M / Series B / Jun 06, 2023 | ||
| Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups. | Series A / May 30, 2023 | ||
| See all 6 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does KCK Medtech invest in?
KCK Medtech invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact KCK Medtech?
Public channels for KCK Medtech include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KCK Medtech?
The team at KCK Medtech includes John White (Managing Director) and Susan P Stimson (Executive In Residence). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
